Development Stage contractual stage started with the approval, by ANP, of the Development Plan proposed by the Concessionaire and which continues during the production phase while investments in xxxxx, equipment and facilities are necessary for the production of Oil and Natural Gas in accordance with the Best Practices of the Oil Industry.
Development Stage. The Development Stage of this RE Contract shall be for a period of three (3) years from the date of execution of this RE Contract during which the RE DEVELOPER shall secure Financial Closing, undertake the development, construction, installation, test and commissioning of the Project, and until COD; otherwise, the term of this RE Contract shall automatically expire.
Development Stage. The Company was organized as a Texas corporation on April 21, 1989 and changed its jurisdiction of incorporation on January 26, 1995 by becoming a Utah corporation. Since it has not sustained profitable operations in any of its market sectors during the periods reflected in the attached SEC reports, the Company must be considered a development stage enterprise with limited prior operating history. Each investor should be advised that, historically and statistically, development stage entities constitute a greater risk of loss of investment than investment in a seasoned company.
Development Stage a. Goal: to prepare an analytically validated, Investigational Use Only Assay using the […***…] antibody, the Benchmark ULTRA platform and OptiView detection and verified to the United States’ FDA specifications that may be used to select patients in registrational trial(s) of BLU-554 in hepatocellular carcinoma (“HCC”).
Development Stage. Upon submission of the Declaration of Commerciality by the RE DEVELOPER, as confirmed by the DEPARTMENT through the issuance of a Certificate of Confirmation of Commerciality, this RE CONTRACT shall remain in force for the balance of a period of twenty-five (25) years from Effective Date: Provided, That at the option of the RE DEVELOPER, by written notice to the DEPARTMENT not later than one (1) year prior to the expiration of the initial twenty-five (25)-year period and so long as the RE DEVELOPER is not in default of any material obligations under this RE Contract, the DEPARTMENT may approve the extension of this RE Contract for another twenty-five (25) years, subject to the terms and conditions to be mutually agreed upon by the Parties.
Development Stage. Upon submission of the DOC by the RE DEVELOPER, as confirmed by the DEPARTMENT through the issuance of a COCOC, this RE Contract shall remain in force for the balance of a period of twenty-five (25) years from Effective Date: Provided, That at the option of the RE DEVELOPER, by written notice to the DEPARTMENT not earlier than two (2) years but not later than one
Development Stage. Upon submission of the Declaration of Commerciality by the RE DEVELOPER, as confirmed by the DEPARTMENT through the issuance of a Certificate of Confirmation of Commerciality, this RE CONTRACT shall remain in force for the balance of a period of twenty-five (25) years from Effective Date: Provided, That at the option of the RE DEVELOPER, by written notice to the DEPARTMENT not later than one (1) year prior to the expiration of the initial twenty-five (25)-year period, and so long as the RE DEVELOPER is not in default of any material obligations under this RE Contract, the DEPARTMENT may approve the extension of this RE Contract for another twenty-five (25) years, subject to the terms and conditions to be mutually agreed upon by the Parties: Provided further, That the RE DEVELOPER may opt to apply for an extension not later than one (1) year from Commercial Operation Date, in which case, the balance of the first 25 year Contract Term, if any, shall be deemed waived.
Development Stage. (a) In consideration of the payments by Ferring pursuant to Section 2 (b) , Medi-Ject will use its best efforts diligently to develop the Product to meet the specifications set forth in Schedule B with a target completion date on or before July 1, 1994. During such development stage, Medi-Ject will provide Ferring with needle-free administration devices for the purpose of laboratory tests and pre-clinical trials. Ferring will provide Medi-Ject with the results of such tests and trials, which Medi-Ject may use as part of a Drug Master File in device applications with Health Regulatory Agencies.
Development Stage. 1.1.1 [***] Aptuit will furnish and install a [***] to be placed in the Kansas City facility [***] This will be at no cost to Iroko.
